Ventricular tachycardia incidence and erythrocyte membranes β-adrenoreactivity in patients with implanted cardioverter-defibrillator.
Tariel A AtabekovRoman E BatalovTatiana Yu RebrovaSergey N KrivolapovElvira F MuslimovaMikhail S KhlyninSergey A AfanasievSergey V PopovPublished in: Pacing and clinical electrophysiology : PACE (2022)
In patients with CAD and ICD erythrocyte membranes β-adrenoreactivity indicator 51.26% or lower is the predictor of VT episodes.